| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H32O9 |
| Molecular Weight | 536.5697 |
| Optical Activity | UNSPECIFIED |
| Additional Stereochemistry | Yes |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
| Stereo Comments | AXIAL, S |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C(OC)=C1OC)C3=C(OC)C4=C(OCO4)C=C3[C@H](OC(=O)C5=CC=CC=C5)[C@@](C)(O)[C@@H](C)C2
InChI
InChIKey=OFDWKHIQKPKRKY-DSASHONVSA-N
InChI=1S/C30H32O9/c1-16-12-18-13-20(33-3)24(34-4)26(35-5)22(18)23-19(14-21-25(27(23)36-6)38-15-37-21)28(30(16,2)32)39-29(31)17-10-8-7-9-11-17/h7-11,13-14,16,28,32H,12,15H2,1-6H3/t16-,28-,30-/m0/s1
| Molecular Formula | C30H32O9 |
| Molecular Weight | 536.5697 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 6.55 µM [IC50] | |||
| 1.02 µM [IC50] |
